Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
anthrax toxin protective antigen + H2O
?
-
-
-
?
dipththeria toxin + H2O
?
-
-
-
?
envelope glycoprotein gp160
?
well activated by PaCE4
-
-
?
human immunodeficiency virus type 1 Vpr + H2O
?
undergoes proteolytic processing at a very well conserved proprotein convertase cleavage site, R85QRR88-/-, proprotein convertases PC5 and PACE4 can efficiently process extracellular Vpr
-
-
?
insulin proreceptor + H2O
?
-
-
-
?
insulin receptor isoform B zymogen + H2O
mature insulin receptor isoform B + ?
L-pyroglutamyl-Arg-Thr-Lys-Arg-4-methylcoumaryl 7-amide + H2O
?
-
-
-
?
L-pyroglutamyl-RTKR-4-methylcoumarin 7-amide + H2O
?
-
-
-
?
low density lipoprotein receptor-elated protein + H2O
?
-
-
-
?
pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
?
pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O
pGlu-Arg-Thr-Lys-Arg + 7-amino-4-methylcoumarin
-
-
-
?
pro-beta site APP cleaving enzyme + H2O
beta site APP cleaving enzyme + ?
-
i.e. BACE, weak substrate
-
?
pro-complement C3 + H2O
?
-
-
-
?
pro7B2 + H2O
7B2 + ?
-
PACE4-A
-
?
proalbumin + H2O
albumin + ?
-
-
-
?
Pyr-Arg-Thr-Lys-Arg-4-methylcoumarin-7-amide + H2O
Pyr-Arg-Thr-Lys-Arg + 7-amino-4-methylcoumarin
-
-
-
ir
von Willebrand factor precursor + H2O
mature von Willebrand factor + ?
additional information
?
-
insulin receptor isoform B zymogen + H2O
mature insulin receptor isoform B + ?
-
-
-
?
insulin receptor isoform B zymogen + H2O
mature insulin receptor isoform B + ?
maturation
-
-
?
von Willebrand factor precursor + H2O
mature von Willebrand factor + ?
-
-
-
?
von Willebrand factor precursor + H2O
mature von Willebrand factor + ?
-
-
-
?
von Willebrand factor precursor + H2O
mature von Willebrand factor + ?
-
-
?
von Willebrand factor precursor + H2O
mature von Willebrand factor + ?
-
cleavage requires both the P4 arginine and the P2 lysine
-
?
additional information
?
-
-
enzyme cleaves at sites with paired basic amino acid residues
-
?
additional information
?
-
-
no substrate: profactor IX
-
?
additional information
?
-
-
no substrate: Pseudomonas exotoxin A
-
?
additional information
?
-
-
PACE4-CS recognizes the motifs X-Ala and X-Pro
-
?
additional information
?
-
-
enzyme binds tightly to heparin and anchors heparan sulfate proteoglycans at the extracellular matrix, role in spatiotemporal regulation of TGFbeta-related factors' biological activity
-
?
additional information
?
-
substrate cleavage analysis
-
-
?
additional information
?
-
-
substrate cleavage analysis
-
-
?
additional information
?
-
no activity with insulin receptor isoform A zymogen
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A23187
-
if reticulocalbin-3 binds to proPACE4 transiently during its biosynthesis, this Ca2+-specific ionophore can block the maturation of proPACE4 to PACE4, accumulation of the proPaCE4-recticulocalbin-3 complex in the cells
Ac-(D)LLLLRVK-2,3-dehydroagmatine
-
Ac-(D)LLLLRVK-4-amidinobenzylamide
-
Ac-LLLLR-((2S)-amino-3S-guanidinobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 40
Ac-LLLLR-((2S,3R)-diaminobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 9
Ac-LLLLR-((2S,3S)-diaminobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 18
Ac-LLLLR-(2,3-diaminobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 12
Ac-LLLLR-(2,3-diaminopropionyl)-KR-NH2
Ki(furin)/Ki(PACE4): 51
Ac-LLLLR-(2-amino-3-guanidinopropionyl)-KR-NH2
Ki(furin)/Ki(PACE4): 19
Ac-LLLLR-(2-amino-4-guanidinobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 10
Ac-LLLLR-Orn-KR-NH2
Ki(furin)/Ki(PACE4): 21
Ac-LLLLRAKR-NH2
Ki(furin)/Ki(PACE4): 7
Ac-LLLLRKKR-NH2
Ki(furin)/Ki(PACE4): 18
Ac-LLLLRRKR-NH2
Ki(furin)/Ki(PACE4): 12
Ac-LLLLRVK-2,3-dehydroagmatine
-
Ac-LLLLRVK-4-amidinobenzylamide
-
Ac-[C8](D)LLLLRVK-4-amidinobenzylamide
-
Ac-[C8]LLLLRVK-4-amidinobenzylamide
-
Ac-[PEG2](D)LLLLRVK-4-amidinobenzylamide
-
Ac-[PEG8](D)LLLLRVK-2,3-dehydroagmatine
-
Ac-[PEG8](D)LLLLRVK-4-amidinobenzylamide
-
Ac-[PEG8](D)LLLLRVKR-NH2
-
Ac-[PEG8]LLLLRVK-2,3-dehydroagmatine
-
Ac-[PEG8]LLLLRVK-4-amidinobenzylamide
-
alpha1-antitrypsin variant AVRR
-
50% inhibition above 0.002 mM
-
alpha1-antitrypsin variant PDX
-
50% inhibition above 0.00002 mM, forms a complex with the enzyme
-
alpha1-antitrypsin variant Portland
-
contains a minimal consensus sequence (Arg-X-X-Arg) for efficient cleavage by furin in its reactive site loop
-
alpha1-antitrypsin variant RRRRSA
-
rat alpha-antitrypsin showing substitution of Arg-Arg-Arg-Arg for Ala-Val-Pro-Met352 at P4-P1 and Ala for Leu354 at P2'
-
alpha1-antitrypsin variant RRRRSL
-
rat alpha-antitrypsin showing substitution of Arg-Arg-Arg-Arg for Ala-Val-Pro-Met352 at P4-P1
-
alpha1-antitrypsin variant RVRR
-
Ca2+
-
Ca2+ ionophore inhibits protein maturation
carboxyterminal sequence of PACE4
-
inhibits autocatalytic processing
-
decanoyl-Arg-Val-Lys-Arg-chloromethylketone
-
EDTA
-
85% inhibition at 20 mM
EGTA
-
inhibits at 0.5-2 mM
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
-
H2N-[C8](D)LLLLRVKR-NH2
-
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
-
H2N-[C8]LLLLRVK-4-amidinobenzylamide
-
phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide
-
-
reticulocalbin-1
-
reduces efficiency of PACE4 secretion by 21%
-
[C8](D)LLLLRVK-2,3-dehydroagmatine
-
[C8](D)LLLLRVK-4-amidinobenzylamide
-
[C8]LLLLRVK-2,3-dehydroagmatine
-
[C8]LLLLRVK-4-amidinobenzylamide
-
Ac-LLLLRVKR-NH2
-
Ac-LLLLRVKR-NH2
Ki(furin)/Ki(PACE4): 20
alpha1-antitrypsin variant RVRR
-
50% inhibition at 0.000005 mM, forms a complex with the enzyme
-
alpha1-antitrypsin variant RVRR
-
-
-
additional information
-
no inhibitor: alpha1-antitrypsin
-
additional information
-
not inhibited by alpha1-antitrypsin variant AVRR
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma
Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours.
Adenocarcinoma
PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
Anemia
Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Anthrax
A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen.
Anthrax
Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain.
Breast Neoplasms
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Breast Neoplasms
PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
Breast Neoplasms
PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells.
Breast Neoplasms
Pro-protein convertase gene expression in human breast cancer.
Carcinogenesis
Enhanced UV-Induced Skin Carcinogenesis in Transgenic Mice Overexpressing Proprotein Convertases.
Carcinogenesis
Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability.
Carcinogenesis
PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression.
Carcinogenesis
Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Carcinoma
Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours.
Carcinoma
Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability.
Carcinoma
Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4.
Carcinoma
PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression.
Carcinoma
Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Carcinoma
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.
Carcinoma
Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression.
Carcinoma, Non-Small-Cell Lung
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.
Carcinoma, Squamous Cell
Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours.
Carcinoma, Squamous Cell
Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).
Carcinoma, Squamous Cell
Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Choriocarcinoma
The expression of proprotein convertase PACE4 is highly regulated by Hash-2 in placenta: possible role of placenta-specific basic helix-loop-helix transcription factor, human achaete-scute homologue-2.
Diphtheria
Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain.
Endometrial Neoplasms
Proprotein convertases in post-menopausal endometrial cancer: Distinctive regulation and non-invasive diagnosis.
Hemochromatosis
Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Hyperthyroidism
PACE4: a subtilisin-like endoprotease prevalent in the anterior pituitary and regulated by thyroid status.
Lung Neoplasms
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.
Lymphatic Metastasis
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.
Melanoma
Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma.
Nasopharyngeal Carcinoma
PACE4 Expression is a Novel Independent Prognostic Factor in Nasopharyngeal Carcinoma.
Neoplasm Metastasis
Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).
Neoplasm Metastasis
Enhanced UV-Induced Skin Carcinogenesis in Transgenic Mice Overexpressing Proprotein Convertases.
Neoplasm Metastasis
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.
Neoplasm Metastasis
Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
Neoplasm Metastasis
PACE4 Expression is a Novel Independent Prognostic Factor in Nasopharyngeal Carcinoma.
Neoplasm Metastasis
PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways.
Neoplasm Metastasis
Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma.
Neoplasm Metastasis
Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Neoplasms
Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours.
Neoplasms
Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.
Neoplasms
Engineering of alpha1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2' residue in stable complex formation of the serpin with proprotein convertase.
Neoplasms
Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).
Neoplasms
Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.
Neoplasms
Enhanced UV-Induced Skin Carcinogenesis in Transgenic Mice Overexpressing Proprotein Convertases.
Neoplasms
Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.
Neoplasms
Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability.
Neoplasms
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.
Neoplasms
Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
Neoplasms
Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
Neoplasms
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
Neoplasms
Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells.
Neoplasms
Liver-Specific Inactivation of the Proprotein Convertase FURIN Leads to Increased Hepatocellular Carcinoma Growth.
Neoplasms
Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4.
Neoplasms
miR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway.
Neoplasms
Molecular Validation of PACE4 as a Target in Prostate Cancer.
Neoplasms
Multi-Leu PACE4 Inhibitor Retention within Cells Is PACE4 Dependent and a Prerequisite for Antiproliferative Activity.
Neoplasms
PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression.
Neoplasms
PACE4 Expression is a Novel Independent Prognostic Factor in Nasopharyngeal Carcinoma.
Neoplasms
PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction increased apoptosis and impaired neovascularisation.
Neoplasms
PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
Neoplasms
PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways.
Neoplasms
PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells.
Neoplasms
PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer.
Neoplasms
PACE4-based molecular targeting of prostate cancer using an engineered ??Cu-radiolabeled peptide inhibitor.
Neoplasms
Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma.
Neoplasms
Pro-protein convertase gene expression in human breast cancer.
Neoplasms
Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Neoplasms
Proprotein convertases in post-menopausal endometrial cancer: Distinctive regulation and non-invasive diagnosis.
Neoplasms
Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Neoplasms
Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Neoplasms
Role of proprotein convertases in prostate cancer progression.
Neoplasms
The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Neoplasms
Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression.
Neoplasms
Upregulation of PACE4 in Prostate Cancer is not dependent on E2F Transcription Factors.
Nervous System Neoplasms
Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Neuroblastoma
Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1.
Osteoarthritis
A functional polymorphism in the paired basic amino acid-cleaving enzyme 4 gene confers osteoarthritis risk in a population of Eastern China.
Osteoarthritis
A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype.
Osteoarthritis, Knee
A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype.
Ovarian Neoplasms
Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells.
Ovarian Neoplasms
Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
Pancreatic Neoplasms
PACE4 regulates apoptosis in human pancreatic cancer Panc?1 cells via the mitochondrial signaling pathway.
Prostatic Neoplasms
Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.
Prostatic Neoplasms
Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.
Prostatic Neoplasms
Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.
Prostatic Neoplasms
Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
Prostatic Neoplasms
Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
Prostatic Neoplasms
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
Prostatic Neoplasms
Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells.
Prostatic Neoplasms
Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
Prostatic Neoplasms
miR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway.
Prostatic Neoplasms
Molecular Validation of PACE4 as a Target in Prostate Cancer.
Prostatic Neoplasms
Multi-Leu PACE4 Inhibitor Retention within Cells Is PACE4 Dependent and a Prerequisite for Antiproliferative Activity.
Prostatic Neoplasms
Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.
Prostatic Neoplasms
PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction increased apoptosis and impaired neovascularisation.
Prostatic Neoplasms
PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
Prostatic Neoplasms
PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways.
Prostatic Neoplasms
PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer.
Prostatic Neoplasms
PACE4-based molecular targeting of prostate cancer using an engineered ??Cu-radiolabeled peptide inhibitor.
Prostatic Neoplasms
Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.
Prostatic Neoplasms
Proprotein convertase inhibition: Paralyzing the cell's master switches.
Prostatic Neoplasms
Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.
Prostatic Neoplasms
Role of proprotein convertases in prostate cancer progression.
Prostatic Neoplasms
The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.
Prostatic Neoplasms
Upregulation of PACE4 in Prostate Cancer is not dependent on E2F Transcription Factors.
Skin Neoplasms
Enhanced UV-Induced Skin Carcinogenesis in Transgenic Mice Overexpressing Proprotein Convertases.
Spinal Cord Injuries
Gene expression alterations of neurotrophins, their receptors and prohormone convertases in a rat model of spinal cord contusion.
Thyroid Neoplasms
Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.
Thyroid Nodule
Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.
Vaccinia
Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammals.
Vaccinia
Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases.
Vaccinia
Comparative proteolytic processing of rat prosomatostatin by the convertases PC1, PC2, furin, PACE4 and PC5 in constitutive and regulated secretory pathways.
Vaccinia
Comparison of substrate specificities against the fusion glycoprotein of virulent Newcastle disease virus between a chick embryo fibroblast processing protease and mammalian subtilisin-like proteases.
Vaccinia
Processing of prothyrotropin-releasing hormone by the family of prohormone convertases.
Vaccinia
Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4.
Vaccinia
Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses.
Vaccinia
Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.04 - 0.21
Ac-(D)LLLLRVK-2,3-dehydroagmatine
0.025 - 0.04
Ac-(D)LLLLRVK-4-amidinobenzylamide
0.07 - 0.15
Ac-(D)LLLLRVKR-NH2
0.07 - 0.09
Ac-LLLLRVK-2,3-dehydroagmatine
0.025 - 0.04
Ac-LLLLRVK-4-amidinobenzylamide
0.1 - 0.18
Ac-LLLLRVKR-NH2
0.16
Ac-[C8](D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04
Ac-[C8]LLLLRVK-4-amidinobenzylamide
0.08
Ac-[C8]LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.07
Ac-[PEG8](D)LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.11 - 0.15
Ac-[PEG8](D)LLLLRVKR-NH2
0.06 - 0.09
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
0.09
H2N-[C8](D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04 - 0.13
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
0.046 - 0.047
H2N-[C8]LLLLRVK-4-amidinobenzylamide
0.015
H2N-[C8]LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.013 - 0.03
[C8]LLLLRVK-2,3-dehydroagmatine
0.04
Ac-(D)LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.21
Ac-(D)LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.025
Ac-(D)LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04
Ac-(D)LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.07
Ac-(D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.15
Ac-(D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.07
Ac-LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.09
Ac-LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.025
Ac-LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04
Ac-LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.1
Ac-LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.18
Ac-LLLLRVKR-NH2
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.04
Ac-[C8]LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04
Ac-[C8]LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.11
Ac-[PEG8](D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.15
Ac-[PEG8](D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.06
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.09
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.04
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.13
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.046
H2N-[C8]LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
0.047
H2N-[C8]LLLLRVK-4-amidinobenzylamide
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.013
[C8]LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.03
[C8]LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in LNCap cells, pH 7.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Taniguchi, T.; Kuroda, R.; Sakurai, K.; Nagahama, M.; Wada, I.; Tsuji, A.; Matsuda, Y.
A critical role for the carboxy terminal region of the proprotein convertase, PACE4A, in the regulation of its autocatalytic activation coupled with secretion
Biochem. Biophys. Res. Commun.
290
878-884
2002
Homo sapiens
brenda
Sucic, J.F.; Moehring, J.M.; Inocencio, N.M.; Luchini, J.W.; Moehring, T.J.
Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain
Biochem. J.
339
639-647
1999
Homo sapiens
brenda
Rehemtulla, A.; Barr, P.J.; Rhodes, C.J.; Kaufman, R.J.
PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE
Biochemistry
32
11586-11590
1993
Homo sapiens
brenda
Tsuji, A.; Sakurai, K.; Kiyokage, E.; Yamazaki, T.; Koide, S.; Toida, K.; Ishimura, K.; Matsuda, Y.
Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix
Biochim. Biophys. Acta
1645
95-104
2003
Homo sapiens
brenda
Pinnix, I.; Council, J.E.; Roseberry, B.; Onstead, L.; Mallender, W.; Sucic, J.; Sambamurti, K.
Convertases other than furin cleave beta-secretase to its mature form
FASEB J.
15
1810-1812
2001
Homo sapiens
brenda
Creemers, J.W.; Groot Kormelink, P.J.; Roebroek, A.J.; Nakayama, K.; Van de Ven, W.J.
Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4
FEBS Lett.
336
65-69
1993
Homo sapiens
brenda
Zhong, M.; Benjannet, S.; Lazure, C.; Munzer, S.; Seidah, N.G.
Functional analysis of human PACE4-A and PACE4-C isoforms: identification of a new PACE4-CS isoform
FEBS Lett.
396
31-36
1996
Homo sapiens
brenda
Nagahama, M.; Taniguchi, T.; Hashimoto, E.; Imamaki, A.; Mori, K.; Tsuji, A.; Matsuda, Y.
Biosynthetic processing and quaternary interactions of proprotein convertase SPC4 (PACE4)
FEBS Lett.
434
155-159
1998
Homo sapiens
brenda
Mori, K.; Kii, S.; Tsuji, A.; Nagahama, M.; Imamaki, A.; Hayashi, K.; Akamatsu, T.; Nagamune, H.; Matsuda, Y.
A novel human PACE4 isoform, PACE4E is an active processing protease containing a hydrophobic cluster at the carboxy terminus
J. Biochem.
121
941-948
1997
Homo sapiens (P29122), Homo sapiens
brenda
Mori, K.; Imamaki, A.; Nagata, K.; Yonetomi, Y.; Kiyokage-Yoshimoto, R.; Martin, T.J.; Gillespie, M.T.; Nagahama, M.; Tsuji, A.; Matsuda, Y.
Subtilisin-like proprotein convertases, PACE4 and PC8, as well as furin, are endogenous proalbumin convertases in HepG2 cells
J. Biochem.
125
627-633
1999
Homo sapiens
brenda
Tsuji, A.; Ikoma, T.; Hashimoto, E.; Matsuda, Y.
Development of selectivity of alpha1-antitrypsin variant by mutagenesis in its reactive site loop against proprotein convertase. A crucial role of the P4 arginine in PACE4 inhibition
Protein Eng.
15
123-130
2002
Homo sapiens
brenda
Tsuji, A.; Kikuchi, Y.; Sato, Y.; Koide, S.; Yuasa, K.; Nagahama, M.; Matsuda, Y.
A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4
Biochem. J.
396
51-59
2006
Homo sapiens
brenda
Mains, R.E.
Proprotein convertase PACE4
Handbook of Proteolytic Enzymes (Barrett, A. J. , Rawlings, N. D. , Woessner, J. F. , Eds. ) Academic Press
2
1871-1874
2004
Aplysia sp., Mus musculus, Homo sapiens (P29122), Rattus norvegicus (Q63415)
-
brenda
Lapierre, M.; Siegfried, G.; Scamuffa, N.; Bontemps, Y.; Calvo, F.; Seidah, N.G.; Khatib, A.M.
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells malignant phenotypes: role of tissue inhibitors of metalloproteinase-1
Cancer Res.
67
9030-9034
2007
Homo sapiens
brenda
Page, R.E.; Klein-Szanto, A.J.; Litwin, S.; Nicolas, E.; Al-Jumaily, R.; Alexander, P.; Godwin, A.K.; Ross, E.A.; Schilder, R.J.; Bassi, D.E.
Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer
Cell. Oncol.
29
289-299
2007
Homo sapiens
brenda
Yuasa, K.; Suzue, K.; Nagahama, M.; Matsuda, Y.; Tsuji, A.
Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression
Gene
402
103-110
2007
Homo sapiens
brenda
Seidah, N.G.; Mayer, G.; Zaid, A.; Rousselet, E.; Nassoury, N.; Poirier, S.; Essalmani, R.; Prat, A.
The activation and physiological functions of the proprotein convertases
Int. J. Biochem. Cell Biol.
40
1111-1125
2008
Homo sapiens
brenda
Tsuji, A.; Kanie, H.; Makise, H.; Yuasa, K.; Nagahama, M.; Matsuda, Y.
Engineering of alpha 1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2 residue in stable complex formation of the serpin with proprotein convertase
Protein Eng. Des. Sel.
20
163-170
2007
Homo sapiens
brenda
Freyer, C.; Kilpatrick, L.M.; Salamonsen, L.A.; Nie, G.
Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium
Reproduction
133
1189-1197
2007
Homo sapiens (P29122), Homo sapiens
brenda
Remacle, A.G.; Shiryaev, S.A.; Oh, E.S.; Cieplak, P.; Srinivasan, A.; Wei, G.; Liddington, R.C.; Ratnikov, B.I.; Parent, A.; Desjardins, R.; Day, R.; Smith, J.W.; Lebl, M.; Strongin, A.Y.
Substrate cleavage analysis of furin and related proprotein convertases. A comparative study
J. Biol. Chem.
283
20897-20906
2008
Homo sapiens (P29122), Homo sapiens
brenda
Xiao, Y.; Chen, G.; Richard, J.; Rougeau, N.; Li, H.; Seidah, N.G.; Cohen, E.A.
Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases
Virology
372
384-397
2008
Homo sapiens (Q6UW60), Homo sapiens
brenda
Fuller, J.A.; Brun-Zinkernagel, A.M.; Clark, A.F.; Wordinger, R.J.
Subtilisin-like proprotein convertase expression, localization, and activation in the human retina and optic nerve head
Invest. Ophthalmol. Vis. Sci.
50
5759-5768
2009
Homo sapiens
brenda
Kara, I.; Poggi, M.; Bonardo, B.; Govers, R.; Landrier, J.F.; Tian, S.; Leibiger, I.; Day, R.; Creemers, J.W.; Peiretti, F.
The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2)
J. Biol. Chem.
290
2812-2821
2015
Homo sapiens (P29122)
brenda
Kwiatkowska, A.; Couture, F.; Levesque, C.; Ly, K.; Beauchemin, S.; Desjardins, R.; Neugebauer, W.; Dory, Y.L.; Day, R.
Novel insights into structure-activity relationships of N-terminally modified PACE4 inhibitors
ChemMedChem
11
289-301
2016
Homo sapiens (P29122)
brenda
Dianati, V.; Shamloo, A.; Kwiatkowska, A.; Desjardins, R.; Soldera, A.; Day, R.; Dory, Y.L.
Rational design of a highly potent and selective peptide inhibitor of PACE4 by salt bridge interaction with D160 at position P3
ChemMedChem
12
1169-1172
2017
Homo sapiens (P29122)
brenda
Yao, Z.; Sun, B.; Hong, Q.; Yan, J.; Mu, D.; Li, J.; Sheng, H.; Guo, H.
PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways
Drug Des. Devel. Ther.
9
5911-5923
2015
Homo sapiens (P29122), Homo sapiens
brenda
Lin, Y.E.; Wu, Q.N.; Lin, X.D.; Li, G.Q.; Zhang, Y.J.
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients
J. Thorac. Dis.
7
850-860
2015
Homo sapiens (P29122), Homo sapiens
brenda
Wang, F.; Wang, L.; Pan, J.
PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells
Mol. Med. Rep.
11
698-704
2015
Homo sapiens (P29122), Homo sapiens
brenda
Tian, X.F.; Huang, G.M.; Zang, H.L.; Cao, H.
PACE4 regulates apoptosis in human pancreatic cancer Panc-1 cells via the mitochondrial signaling pathway
Mol. Med. Rep.
14
5205-5210
2016
Homo sapiens (P29122), Homo sapiens
brenda